Skip to content

Clinical trials

Non-alcoholic Fatty Liver Disease trials in Mexico

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Country / region: Mexico Clear all

38 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20153
20162
20173
20181
20195
20203
20217
20221
20235
20245
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Terminated9
Recruiting6
Active, not recruiting5
Unknown status4
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Akero Therapeutics, Inc3
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran3
Merck Sharp & Dohme LLC3
89bio, Inc.2
Eli Lilly and Company2
Gilead Sciences2
AB Biotics, SA1
AstraZeneca1
Fundación Clínica Médica Sur1
Galectin Therapeutics Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease38
Fatty Liver6
Fibrosis6
Liver Cirrhosis5
Liver Diseases5
Obesity4
Digestive System Diseases2
Metabolic Diseases2
Diabetes Mellitus1
Esophageal and Gastric Varices1

Trials

Showing 26 to 38 of 38. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.